Serum leptin levels, hepatic leptin receptor transcription, and clinical predictors of non-alcoholic steatohepatitis in obese bariatric surgery patients

Non-alcoholic steatohepatitis (NASH) is a major cause of liver disease in morbidly obese patients. Clinical predictors of NASH remain elusive, as do molecular mechanisms of pathogenesis. A series of 35 morbidly obese patients undergoing bariatric surgery had a liver biopsy performed for standard his...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Surgical endoscopy 2007-09, Vol.21 (9), p.1593-1599
Hauptverfasser: LE, D, MARKS, D, O'ROURKE, R. W, LYLE, E, CORLESS, C. L, DIGGS, B. S, JOBE, B. A, KAY, T, DEVENEY, C. W, WOLFE, B. M, ROBERTS, C. T
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1599
container_issue 9
container_start_page 1593
container_title Surgical endoscopy
container_volume 21
creator LE, D
MARKS, D
O'ROURKE, R. W
LYLE, E
CORLESS, C. L
DIGGS, B. S
JOBE, B. A
KAY, T
DEVENEY, C. W
WOLFE, B. M
ROBERTS, C. T
description Non-alcoholic steatohepatitis (NASH) is a major cause of liver disease in morbidly obese patients. Clinical predictors of NASH remain elusive, as do molecular mechanisms of pathogenesis. A series of 35 morbidly obese patients undergoing bariatric surgery had a liver biopsy performed for standard histologic analysis. In addition, RNA was obtained from liver tissue and analyzed for leptin receptor gene expression. Regression analysis was used to correlate clinical variables, including serum leptin levels and hepatic leptin receptor gene expression, with the presence of histologically confirmed NASH. Of the 35 subjects enrolled, 29% had steatosis only, 60% had NASH, and 11% had normal liver histology. Among the clinical variables studied, only diabetes mellitus was an independent predictor of NASH. There was a trend toward lower levels of mRNA encoding the long form of the leptin receptor in hepatic tissue from patients with NASH compared to those with steatosis only. Diabetes mellitus is associated with an increased risk of NASH in obese patients. Downregulation of hepatic leptin receptor may play a role in the pathogenesis of NASH.
doi_str_mv 10.1007/s00464-006-9185-5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68223708</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68223708</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-f6a30c9302275aa784bb2fee10f54de07e27a5dd53a1366d3513dfda4b416ade3</originalsourceid><addsrcrecordid>eNpdkctq3TAQhkVpaE7SPkA3RRSSVdzqYln2MoReAoEu2q7FWBo3Cj6SK8mFvEketzLnlEBXEsM3vzTzEfKWsw-cMf0xM9Z2bcNY1wy8V416QXa8laIRgvcvyY4NkjVCD-0pOcv5gVV84OoVOeVaDK3kbEeevmNa93TGpfhQjz845yt6jwsUb_-VE9p6iYmWBCHb5Gs1hisKwVE7--AtzHRJ6LytVKZxoiGGBmYb7-Ncc3JBKPGQWnymNTOOmJGOkDyUtCFr-oXpkW4IhpJfk5MJ5oxvjuc5-fn504-br83dty-3N9d3jZWqK83UgWS2zimEVgC6b8dRTIicTap1yDQKDco5JYHLrnNScekmB-3Y8g4cynNyechdUvy9Yi5m77PFeYaAcc2m64WQmvUVfP8f-BDXFOrfjOB1m5pzViF-gGyKOSeczJL8HtKj4cxszszBmanOzObMqNrz7hi8jnt0zx1HSRW4OAKQ66anKsH6_MwN28t1rr8YnaKu</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>219437110</pqid></control><display><type>article</type><title>Serum leptin levels, hepatic leptin receptor transcription, and clinical predictors of non-alcoholic steatohepatitis in obese bariatric surgery patients</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>LE, D ; MARKS, D ; O'ROURKE, R. W ; LYLE, E ; CORLESS, C. L ; DIGGS, B. S ; JOBE, B. A ; KAY, T ; DEVENEY, C. W ; WOLFE, B. M ; ROBERTS, C. T</creator><creatorcontrib>LE, D ; MARKS, D ; O'ROURKE, R. W ; LYLE, E ; CORLESS, C. L ; DIGGS, B. S ; JOBE, B. A ; KAY, T ; DEVENEY, C. W ; WOLFE, B. M ; ROBERTS, C. T</creatorcontrib><description>Non-alcoholic steatohepatitis (NASH) is a major cause of liver disease in morbidly obese patients. Clinical predictors of NASH remain elusive, as do molecular mechanisms of pathogenesis. A series of 35 morbidly obese patients undergoing bariatric surgery had a liver biopsy performed for standard histologic analysis. In addition, RNA was obtained from liver tissue and analyzed for leptin receptor gene expression. Regression analysis was used to correlate clinical variables, including serum leptin levels and hepatic leptin receptor gene expression, with the presence of histologically confirmed NASH. Of the 35 subjects enrolled, 29% had steatosis only, 60% had NASH, and 11% had normal liver histology. Among the clinical variables studied, only diabetes mellitus was an independent predictor of NASH. There was a trend toward lower levels of mRNA encoding the long form of the leptin receptor in hepatic tissue from patients with NASH compared to those with steatosis only. Diabetes mellitus is associated with an increased risk of NASH in obese patients. Downregulation of hepatic leptin receptor may play a role in the pathogenesis of NASH.</description><identifier>ISSN: 0930-2794</identifier><identifier>EISSN: 1432-2218</identifier><identifier>DOI: 10.1007/s00464-006-9185-5</identifier><identifier>PMID: 17294310</identifier><identifier>CODEN: SUREEX</identifier><language>eng</language><publisher>New York, NY: Springer</publisher><subject>Adult ; Alcohol use ; Bariatric Surgery ; Biological and medical sciences ; Biomarkers - blood ; Biopsy ; Diabetes ; Fatty Liver - diagnosis ; Fatty Liver - etiology ; Female ; Gastroenterology. Liver. Pancreas. Abdomen ; Gastrointestinal surgery ; Gene expression ; Histology ; Humans ; Laparoscopy ; Leptin - blood ; Liver - metabolism ; Liver cirrhosis ; Liver diseases ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; Male ; Medical sciences ; Metabolic diseases ; Middle Aged ; Obesity ; Obesity, Morbid - complications ; Obesity, Morbid - metabolism ; Obesity, Morbid - surgery ; Other diseases. Semiology ; Pathogenesis ; Patients ; Receptors, Cell Surface - genetics ; Receptors, Cell Surface - metabolism ; Receptors, Leptin ; Risk Factors ; Stomach, duodenum, intestine, rectum, anus ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the digestive system ; Transcription, Genetic ; Variables</subject><ispartof>Surgical endoscopy, 2007-09, Vol.21 (9), p.1593-1599</ispartof><rights>2007 INIST-CNRS</rights><rights>Springer Science+Business Media, LLC 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-f6a30c9302275aa784bb2fee10f54de07e27a5dd53a1366d3513dfda4b416ade3</citedby><cites>FETCH-LOGICAL-c356t-f6a30c9302275aa784bb2fee10f54de07e27a5dd53a1366d3513dfda4b416ade3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19110351$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17294310$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LE, D</creatorcontrib><creatorcontrib>MARKS, D</creatorcontrib><creatorcontrib>O'ROURKE, R. W</creatorcontrib><creatorcontrib>LYLE, E</creatorcontrib><creatorcontrib>CORLESS, C. L</creatorcontrib><creatorcontrib>DIGGS, B. S</creatorcontrib><creatorcontrib>JOBE, B. A</creatorcontrib><creatorcontrib>KAY, T</creatorcontrib><creatorcontrib>DEVENEY, C. W</creatorcontrib><creatorcontrib>WOLFE, B. M</creatorcontrib><creatorcontrib>ROBERTS, C. T</creatorcontrib><title>Serum leptin levels, hepatic leptin receptor transcription, and clinical predictors of non-alcoholic steatohepatitis in obese bariatric surgery patients</title><title>Surgical endoscopy</title><addtitle>Surg Endosc</addtitle><description>Non-alcoholic steatohepatitis (NASH) is a major cause of liver disease in morbidly obese patients. Clinical predictors of NASH remain elusive, as do molecular mechanisms of pathogenesis. A series of 35 morbidly obese patients undergoing bariatric surgery had a liver biopsy performed for standard histologic analysis. In addition, RNA was obtained from liver tissue and analyzed for leptin receptor gene expression. Regression analysis was used to correlate clinical variables, including serum leptin levels and hepatic leptin receptor gene expression, with the presence of histologically confirmed NASH. Of the 35 subjects enrolled, 29% had steatosis only, 60% had NASH, and 11% had normal liver histology. Among the clinical variables studied, only diabetes mellitus was an independent predictor of NASH. There was a trend toward lower levels of mRNA encoding the long form of the leptin receptor in hepatic tissue from patients with NASH compared to those with steatosis only. Diabetes mellitus is associated with an increased risk of NASH in obese patients. Downregulation of hepatic leptin receptor may play a role in the pathogenesis of NASH.</description><subject>Adult</subject><subject>Alcohol use</subject><subject>Bariatric Surgery</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>Biopsy</subject><subject>Diabetes</subject><subject>Fatty Liver - diagnosis</subject><subject>Fatty Liver - etiology</subject><subject>Female</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Gastrointestinal surgery</subject><subject>Gene expression</subject><subject>Histology</subject><subject>Humans</subject><subject>Laparoscopy</subject><subject>Leptin - blood</subject><subject>Liver - metabolism</subject><subject>Liver cirrhosis</subject><subject>Liver diseases</subject><subject>Liver. Biliary tract. Portal circulation. Exocrine pancreas</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Middle Aged</subject><subject>Obesity</subject><subject>Obesity, Morbid - complications</subject><subject>Obesity, Morbid - metabolism</subject><subject>Obesity, Morbid - surgery</subject><subject>Other diseases. Semiology</subject><subject>Pathogenesis</subject><subject>Patients</subject><subject>Receptors, Cell Surface - genetics</subject><subject>Receptors, Cell Surface - metabolism</subject><subject>Receptors, Leptin</subject><subject>Risk Factors</subject><subject>Stomach, duodenum, intestine, rectum, anus</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the digestive system</subject><subject>Transcription, Genetic</subject><subject>Variables</subject><issn>0930-2794</issn><issn>1432-2218</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpdkctq3TAQhkVpaE7SPkA3RRSSVdzqYln2MoReAoEu2q7FWBo3Cj6SK8mFvEketzLnlEBXEsM3vzTzEfKWsw-cMf0xM9Z2bcNY1wy8V416QXa8laIRgvcvyY4NkjVCD-0pOcv5gVV84OoVOeVaDK3kbEeevmNa93TGpfhQjz845yt6jwsUb_-VE9p6iYmWBCHb5Gs1hisKwVE7--AtzHRJ6LytVKZxoiGGBmYb7-Ncc3JBKPGQWnymNTOOmJGOkDyUtCFr-oXpkW4IhpJfk5MJ5oxvjuc5-fn504-br83dty-3N9d3jZWqK83UgWS2zimEVgC6b8dRTIicTap1yDQKDco5JYHLrnNScekmB-3Y8g4cynNyechdUvy9Yi5m77PFeYaAcc2m64WQmvUVfP8f-BDXFOrfjOB1m5pzViF-gGyKOSeczJL8HtKj4cxszszBmanOzObMqNrz7hi8jnt0zx1HSRW4OAKQ66anKsH6_MwN28t1rr8YnaKu</recordid><startdate>20070901</startdate><enddate>20070901</enddate><creator>LE, D</creator><creator>MARKS, D</creator><creator>O'ROURKE, R. W</creator><creator>LYLE, E</creator><creator>CORLESS, C. L</creator><creator>DIGGS, B. S</creator><creator>JOBE, B. A</creator><creator>KAY, T</creator><creator>DEVENEY, C. W</creator><creator>WOLFE, B. M</creator><creator>ROBERTS, C. T</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20070901</creationdate><title>Serum leptin levels, hepatic leptin receptor transcription, and clinical predictors of non-alcoholic steatohepatitis in obese bariatric surgery patients</title><author>LE, D ; MARKS, D ; O'ROURKE, R. W ; LYLE, E ; CORLESS, C. L ; DIGGS, B. S ; JOBE, B. A ; KAY, T ; DEVENEY, C. W ; WOLFE, B. M ; ROBERTS, C. T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-f6a30c9302275aa784bb2fee10f54de07e27a5dd53a1366d3513dfda4b416ade3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Alcohol use</topic><topic>Bariatric Surgery</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>Biopsy</topic><topic>Diabetes</topic><topic>Fatty Liver - diagnosis</topic><topic>Fatty Liver - etiology</topic><topic>Female</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Gastrointestinal surgery</topic><topic>Gene expression</topic><topic>Histology</topic><topic>Humans</topic><topic>Laparoscopy</topic><topic>Leptin - blood</topic><topic>Liver - metabolism</topic><topic>Liver cirrhosis</topic><topic>Liver diseases</topic><topic>Liver. Biliary tract. Portal circulation. Exocrine pancreas</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Middle Aged</topic><topic>Obesity</topic><topic>Obesity, Morbid - complications</topic><topic>Obesity, Morbid - metabolism</topic><topic>Obesity, Morbid - surgery</topic><topic>Other diseases. Semiology</topic><topic>Pathogenesis</topic><topic>Patients</topic><topic>Receptors, Cell Surface - genetics</topic><topic>Receptors, Cell Surface - metabolism</topic><topic>Receptors, Leptin</topic><topic>Risk Factors</topic><topic>Stomach, duodenum, intestine, rectum, anus</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the digestive system</topic><topic>Transcription, Genetic</topic><topic>Variables</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LE, D</creatorcontrib><creatorcontrib>MARKS, D</creatorcontrib><creatorcontrib>O'ROURKE, R. W</creatorcontrib><creatorcontrib>LYLE, E</creatorcontrib><creatorcontrib>CORLESS, C. L</creatorcontrib><creatorcontrib>DIGGS, B. S</creatorcontrib><creatorcontrib>JOBE, B. A</creatorcontrib><creatorcontrib>KAY, T</creatorcontrib><creatorcontrib>DEVENEY, C. W</creatorcontrib><creatorcontrib>WOLFE, B. M</creatorcontrib><creatorcontrib>ROBERTS, C. T</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Surgical endoscopy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LE, D</au><au>MARKS, D</au><au>O'ROURKE, R. W</au><au>LYLE, E</au><au>CORLESS, C. L</au><au>DIGGS, B. S</au><au>JOBE, B. A</au><au>KAY, T</au><au>DEVENEY, C. W</au><au>WOLFE, B. M</au><au>ROBERTS, C. T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serum leptin levels, hepatic leptin receptor transcription, and clinical predictors of non-alcoholic steatohepatitis in obese bariatric surgery patients</atitle><jtitle>Surgical endoscopy</jtitle><addtitle>Surg Endosc</addtitle><date>2007-09-01</date><risdate>2007</risdate><volume>21</volume><issue>9</issue><spage>1593</spage><epage>1599</epage><pages>1593-1599</pages><issn>0930-2794</issn><eissn>1432-2218</eissn><coden>SUREEX</coden><abstract>Non-alcoholic steatohepatitis (NASH) is a major cause of liver disease in morbidly obese patients. Clinical predictors of NASH remain elusive, as do molecular mechanisms of pathogenesis. A series of 35 morbidly obese patients undergoing bariatric surgery had a liver biopsy performed for standard histologic analysis. In addition, RNA was obtained from liver tissue and analyzed for leptin receptor gene expression. Regression analysis was used to correlate clinical variables, including serum leptin levels and hepatic leptin receptor gene expression, with the presence of histologically confirmed NASH. Of the 35 subjects enrolled, 29% had steatosis only, 60% had NASH, and 11% had normal liver histology. Among the clinical variables studied, only diabetes mellitus was an independent predictor of NASH. There was a trend toward lower levels of mRNA encoding the long form of the leptin receptor in hepatic tissue from patients with NASH compared to those with steatosis only. Diabetes mellitus is associated with an increased risk of NASH in obese patients. Downregulation of hepatic leptin receptor may play a role in the pathogenesis of NASH.</abstract><cop>New York, NY</cop><pub>Springer</pub><pmid>17294310</pmid><doi>10.1007/s00464-006-9185-5</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0930-2794
ispartof Surgical endoscopy, 2007-09, Vol.21 (9), p.1593-1599
issn 0930-2794
1432-2218
language eng
recordid cdi_proquest_miscellaneous_68223708
source MEDLINE; SpringerNature Journals
subjects Adult
Alcohol use
Bariatric Surgery
Biological and medical sciences
Biomarkers - blood
Biopsy
Diabetes
Fatty Liver - diagnosis
Fatty Liver - etiology
Female
Gastroenterology. Liver. Pancreas. Abdomen
Gastrointestinal surgery
Gene expression
Histology
Humans
Laparoscopy
Leptin - blood
Liver - metabolism
Liver cirrhosis
Liver diseases
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Male
Medical sciences
Metabolic diseases
Middle Aged
Obesity
Obesity, Morbid - complications
Obesity, Morbid - metabolism
Obesity, Morbid - surgery
Other diseases. Semiology
Pathogenesis
Patients
Receptors, Cell Surface - genetics
Receptors, Cell Surface - metabolism
Receptors, Leptin
Risk Factors
Stomach, duodenum, intestine, rectum, anus
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the digestive system
Transcription, Genetic
Variables
title Serum leptin levels, hepatic leptin receptor transcription, and clinical predictors of non-alcoholic steatohepatitis in obese bariatric surgery patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T15%3A41%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serum%20leptin%20levels,%20hepatic%20leptin%20receptor%20transcription,%20and%20clinical%20predictors%20of%20non-alcoholic%20steatohepatitis%20in%20obese%20bariatric%20surgery%20patients&rft.jtitle=Surgical%20endoscopy&rft.au=LE,%20D&rft.date=2007-09-01&rft.volume=21&rft.issue=9&rft.spage=1593&rft.epage=1599&rft.pages=1593-1599&rft.issn=0930-2794&rft.eissn=1432-2218&rft.coden=SUREEX&rft_id=info:doi/10.1007/s00464-006-9185-5&rft_dat=%3Cproquest_cross%3E68223708%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=219437110&rft_id=info:pmid/17294310&rfr_iscdi=true